CARsgen Therapeutics Adopts New Governance Framework
Company Announcements

CARsgen Therapeutics Adopts New Governance Framework

CARsgen Therapeutics Holdings Ltd. (HK:2171) has released an update.

CARsgen Therapeutics Holdings Ltd. has successfully adopted its eighth amended and restated Memorandum and Articles of Association. The significant corporate update follows a special resolution passed on May 21, 2024, reflecting important governance enhancements for the company.

For further insights into HK:2171 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!